BioCentury
ARTICLE | Company News

Evotec, Merck KGaA deal

December 6, 2010 8:00 AM UTC

Evotec and Merck partnered under the NEU2 consortium to develop preclinical candidates for an undisclosed neurological disease. Evotec will provide its drug discovery technologies and identify small m...